- Report
- March 2024
- 159 Pages
Global
From €2379EUR$2,500USD£2,037GBP
- Report
- July 2020
United States
From €7607EUR$7,995USD£6,513GBP
From €7607EUR$7,995USD£6,513GBP
- Report
- May 2018
Australia
From €7607EUR$7,995USD£6,513GBP
From €7607EUR$7,995USD£6,513GBP
- Report
- May 2018
South Korea
From €7607EUR$7,995USD£6,513GBP
From €7607EUR$7,995USD£6,513GBP
- Report
- October 2020
Europe
From €8558EUR$8,995USD£7,328GBP
- Report
- August 2023
- 82 Pages
Global
From €3500EUR$3,941USD£3,102GBP
- Report
- February 2024
- 132 Pages
Global
From €904EUR$950USD£774GBP
- Report
- March 2020
- 107 Pages
Global
From €4282EUR$4,500USD£3,666GBP
The Infusion Therapy Device market within the context of Cardiovascular Devices is a rapidly growing sector of the medical device industry. These devices are used to deliver medications, fluids, and nutrients directly into the bloodstream. They are used to treat a variety of cardiovascular conditions, including hypertension, arrhythmias, and congestive heart failure. Infusion therapy devices are designed to provide precise and accurate delivery of medications, fluids, and nutrients to the patient. They are also used to monitor and adjust the patient's vital signs.
Infusion therapy devices are available in a variety of sizes and configurations, including portable, handheld, and desktop models. They are typically used in hospitals, clinics, and other healthcare settings. The market for these devices is expected to continue to grow as the demand for more precise and accurate delivery of medications and nutrients increases.
Some of the major companies in the Infusion Therapy Device market include B. Braun, Baxter, Fresenius Kabi, Hospira, and Smiths Medical. Show Less Read more